Great to have The Sam Klein visit us ⁦UCSD Gastroenterology⁩ and ⁦MASLD Research Center⁩ — look forward to continued collaborations!!! ⁦AASLD⁩ ⁦EASLnews⁩ ⁦American Gastroenterological Association (AGA)⁩ ⁦Veeral Ajmera⁩ ⁦Daniel Huang⁩ ⁦Vincent Wong⁩ ⁦Monica Tincopa MD MSc⁩

What are th drugs for Hcc , the terminologies, challenges of HCC mx and checklist prior to use of atezo bev.
Learn it all in this review. Now Journal of Clinical and Experimental Hepatology Dr Ashish Kumar M PREMKUMAR LTSI INASL ILCA Amit G Singal Atoosa Rabiee Liver Fellow Network Daniel Huang #livertwitter

Explore the groundbreaking research on the incidence and predictors of hepatocellular carcinoma in NAFLD patients 🥼 without diagnosed cirrhosis, presented in a nationwide real-world U.S. study.

🔗View the document on link.springer.com/article/10.100…

#heptaology #HepatologyInternational

Prevention of mother-to-child-transmission of HBV🦠is one of the most salient strategies for viral hepatitis elimination. Have a look at this local guideline endorsed by The Hong Kong College of Obstetricians and Gynaecologists🤰🇭🇰 hkmj.org/earlyrelease/h…

Honored to be part of the team for this important work that provides key information on a pressing issue - holding GLP-1RAs before the endoscopies (but, maybe just EGD and double, not Colo?)

🤩We summarized the existing pharmacological therapies for #portalhtn in #cirrhosis Juan G Abraldes

🗝️Etiological tx
✅NSBB
✅Vasoactive agents
✅Statin & metformin

In Press here: shorturl.at/iGKRW

#Livertwitter #GITwitter #MedTwitter #medstudenttwitter

Special thanks to Daniel Huang for his excellent presentation on Natural History of MASLD and Disease Progression at MASH Day!

UCSD MASH Educational day kicking off 🙌🏻
Our favorite Daniel Huang presenting an introduction to MASH and disease progression 📢
MASLD Research Center Rohit Loomba Veeral Ajmera UCSD Gastroenterology

Thank you EASLnews for highlighting our study Journal of Hepatology

So many preventable deaths related to hepatitis B-associated liver cancer and cirrhosis.

Antiviral therapy is safe, effective, but severely underutilized.

HBV antivirals prevent HCC.

What % of pts with HBV get an adequate evaluation to assess treatment eligibility based on AASLD criteria?

What % receive treatment?

👩‍🦰 disadvantaged!

We evaluated 🔼 in 25 centers/>12K pts

Journal of Hepatology

free link:
authors.elsevier.com/a/1j0lccOnAUb9O

Hepatocellular carcinoma screening is associated with reduced mortality even after accounting for lead-time & length-time biases, this study finds. ja.ma/3JEUDCM Amit G Singal Darine Daher Neehar Parikh @drhuangdq Nicole Rich @kanwalfasiha anand kulkarni @bluefaeryliver

📢Check out our article in AJG - The American Journal of Gastroenterology
⬆️ Mortality of obesity-associated GI cancer in low and lower middle income countries
#gitwitter
Karn Wijarnpreecha Ju Dong Yang Mazen Noureddin, MD, MHSc Rashid Lui 雷諾信 Daniel Huang Cheng Han Ng

Chronic #hepatitisB virus infection affects ~296 million people worldwide & is the leading cause of #cirrhosis & #livercancer globally

This REVIEW examines global burden of #HBV & calls for action to eliminate HBV as a public health threat rdcu.be/dFbFL
#WorldLiverDay

Heavy #alcohol consumption is a major cause of morbidity and mortality

This REVIEW examines the plobal epidemiology of alcohol-associated #cirrhosis and #hepatocellularcarcinoma
rdcu.be/dExyu

Antiviral Therapy Found to Improve Long-Term Survival for Patients With HBV- and HCV-Related Hepatocellular Carcinoma Daniel Huang NUS vist.ly/x5fh #livercancer news #livercancer #liverdisease #researchstudy

What is the natural history of MASLD?

What is the median survival after a first decompensating episode?

This study MASLD Research Center provides some answers Rohit Loomba Nabil Noureddin Alina Allen Veeral Ajmera roypounder.apt

onlinelibrary.wiley.com/doi/10.1111/ap…

Arun J. Sanyal awed us with intrapatient reliability in MR so, important to note these agreement/reliability measures in human science [aka clinimetrics]
gut.bmj.com/content/64/7/1… Gut Journal

Today’s #readoftheweek 📚 highlights the increased prevalence of ALD in the elderly, with a burden of AUD comparable with that in the overall population.

Read here this 🔓 #openaccess JHEP Reports article: jhep-reports.eu/article/S2589-…

🙏 @pojsakorndan, @karnjuve, Juan Pablo (JP) Arab, MD ,

Our #ImplementationScience study on #MobileTechnology based #LifestyleIntervention in #MASLD published in Scientific Reports
rdcu.be/dCPes
💠real world implementation results less robust on metabolic & hepatic outcomes
💠⬇️Age & #diabetes correlated with unhealthy diet

Here is the summary of new eligibility criteria for treatment of #HBV from the new ⁦World Health Organization (WHO)⁩ guidelines. HBV >2000 and ALT >ULN will encompass most of patients in our clinics. IMO patient choice still critical. ⁦Hep B Foundation⁩ ⁦British Liver Trust⁩ ⁦ICE-HBV⁩